Related Experiment Video

Updated: Jun 11, 2026

Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein
08:45

Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein

Published on: September 29, 2021

Tyrosine kinases in inflammatory dermatologic disease

Ricardo T Paniagua1, David F Fiorentino2, Lorinda Chung1

  • 1Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Geriatric Research Education and Clinical Center, Palo Alto Department of Veterans Affairs Health Care System, Palo Alto, California.

Journal of the American Academy of Dermatology
|June 30, 2010
PubMed

Insights

Tyrosine kinases (TKs) are enzymes crucial for cell signaling. Inhibiting specific TKs offers a promising new therapy for autoimmune and inflammatory skin diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Tyrosine kinases (TKs) are enzymes regulating critical cellular functions like proliferation and survival.
  • Aberrant TK signaling is implicated in the pathogenesis of autoimmune and inflammatory diseases.
  • TKs play a role in inflammatory dermatologic conditions.

Purpose of the Study:

  • To review TK signaling in inflammatory skin diseases.
  • To evaluate strategies for inhibiting aberrant TK pathways.
  • To discuss future drug development for TK-targeted therapies.

Main Methods:

  • Literature review of tyrosine kinase signaling.
  • Analysis of TK inhibitors in dermatologic disease models.
  • Discussion of current and emerging therapeutic strategies.

Main Results:

  • Specific TKs are key drivers in inflammatory dermatologic diseases.
  • Small-molecule TK inhibitors represent a novel therapeutic class.
  • Targeting TKs shows potential for specific patient subsets.

Conclusions:

  • TK signaling pathways are critical targets for treating inflammatory skin conditions.
  • TK inhibitors offer a promising avenue for novel dermatologic therapies.
  • Further drug development is warranted to harness TK inhibition for patient benefit.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...